Synovics Pharmaceuticals Inc SYVC:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 08/04/23 EDT
0.0001UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0001
  • 52 Week High0.00
  • 52 Week High Date08/04/23
  • 52 Week Low0.00
  • 52 Week Low Date08/04/23

Key Stats

  • Market Cap2,982.736
  • Shares Out29.83M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0001
  • 52 Week High0.00
  • 52 Week High Date08/04/23
  • 52 Week Low0.00
  • 52 Week Low Date08/04/23
  • Market Cap2,982.736
  • Shares Out29.83M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-3.643M
  • ROE (TTM)-647.08%
  • Revenue (TTM)19.091M
  • Gross Margin (TTM)23.39%
  • Net Margin (TTM)-26.42%
  • Debt To Equity (MRQ)-794.95%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Synovics Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include...
Ronald Lane
Chairman of the Board, Secretary
Jyotindra Gange
Interim Principal Executive Officer, Director
Mahendra Desai
Chief Financial Officer
Address
5360 NW 35th Ave
Fort Lauderdale, FL
33309-6314
United States